Marcel Karperien, professor at the department of Developmental Bioengineering, developed an injectable hydrogel to repair damaged cartilage and potentially prevent the onset of osteoarthritis. Together with his colleagues from TechMed Centre, UMC Utrecht and Hy2Care, he optimized the gel to make it suitable for use in humans.
Hy2Care BV, a spin-off of the University of Twente founded by professor Marcel Karperien, has managed to raise € 3.7 million in funding. The startup, which has developed injectable hydrogels for the treatment of cartilage defects, will now be able to commercialize its technology for veterinary use as well as initiate human trials.
Three Twente startups - 20face, Hy2Care and LipoCoat – have entered the Academic Startup Competition. As such, the UT spin-offs are in the running to become one of the ten best ’Dutch Pioneering Innovations from Science’.